Blog

Rahul Gosain: Recap ASCO 23 plenary discussion, importance of MultiD approach, as you get ready for ASCO 24

Photo taken from Oncology Brothers/X

May 28, 2024, 07:58

Rahul Gosain: Recap ASCO 23 plenary discussion, importance of MultiD approach, as you get ready for ASCO 24

Rahul Gosain, Director of Regional Infusion Services at

“GI Series: As you get ready for ASCO 24, Rohit Gosain, MD and I recap ASCO 23 plenary discussion, importance of MultiD approach, and the current landscape of Rectal Cancer with Deb Schrag & Krishan Jethwa

Selective omission of Surgery, XRT, and Chemo is the key.

Full discussion:

Also on the “Oncology Brothers” podcast.”

Source: Rahul Gosain/LinkedIn
.

ASCO 23 ASCO 24 cancer current landscape of rectal cancer Deb Schrag GI Series Krishan Jethwa MultiD approach OncoDaily Oncology Oncology Brothers podcast plenary discussion Rahul Gosain rectal cancer rectal cancer treatment Rohit Gosain MD selective omission of chemo selective omission of surgery selective omission of XRT Wilmot Cancer Institute

Dr. Richard Pazdur's 25 Year WAR on Cancer at the FDA!

China Anti-Cancer Association (CACA) and OncoDaily Announce Strategic Partnership to Advance Global Cancer Care

Donald Trump: Thrilled to announce Robert F. Kennedy Jr. as The United States Secretary of HHS

Overview of ASCO Breakthrough

Robert De Niro and Prostate Cancer: How He Went Against, How He Survived, and More

Special Coverage